鹰瞳科技-B(02251) - 2023 - 中期财报

Our R&D expenses decreased by 18.8% from RMB69.6 million for the six months ended June 30, 2022 to RMB56.5 million for the six months ended June 30, 2023, primarily due to the decrease in employee benefits expenses as we continue to streamline corporate operations and prioritize targeted R&D activities. Our revenue increased by 120.6% from RMB37.4 million for the six months ended June 30, 2022 to RMB82.5 million for the six months ended June 30, 2023. The increase is primarily attributable to (i) a 137% yea ...